CStone Pharmaceuticals (2616.HK)

HKD 2.9

(2.84%)

Total Debt Summary of CStone Pharmaceuticals

CStone Pharmaceuticals's latest annual total debt in 2023 was 363.44 Million CNY , up 26.95% from previous year.
CStone Pharmaceuticals's latest quarterly total debt in 2024 Q1 was 306.42 Million CNY , down -3.94% from previous quarter.
CStone Pharmaceuticals reported annual total debt of 286.29 Million CNY in 2022, up 64.35% from previous year.
CStone Pharmaceuticals reported annual total debt of 174.19 Million CNY in 2021, up 107.73% from previous year.
CStone Pharmaceuticals reported quarterly total debt of 306.42 Million CNY for 2024 Q2, up 9.22% from previous quarter.
CStone Pharmaceuticals reported quarterly total debt of 187.68 Million CNY for 2023 Q1, down -34.44% from previous quarter.

Annual Total Debt Chart of CStone Pharmaceuticals (2023 - 2016)

Historical Annual Total Debt of CStone Pharmaceuticals (2023 - 2016)

Year	Total Debt	Total Debt Growth
2023	363.44 Million CNY	26.95%
2022	286.29 Million CNY	64.35%
2021	174.19 Million CNY	107.73%
2020	83.85 Million CNY	1830.46%
2019	4.34 Million CNY	0.0%
2018	- CNY	0.0%
2017	- CNY	0.0%
2016	- CNY	0.0%

Year	Total Debt	Total Debt Growth
2024 Q1	306.42 Million CNY	-3.94%
2024 Q2	306.42 Million CNY	9.22%
2023 Q1	187.68 Million CNY	-34.44%
2023 Q3	330.12 Million CNY	75.89%
2023 Q2	187.68 Million CNY	0.0%
2023 FY	363.44 Million CNY	26.95%
2023 Q4	318.98 Million CNY	-3.37%
2022 Q1	192.02 Million CNY	10.24%
2022 FY	286.29 Million CNY	64.35%
2022 Q4	286.29 Million CNY	14.54%
2022 Q3	249.93 Million CNY	5.55%
2022 Q2	236.79 Million CNY	23.31%
2021 Q4	174.19 Million CNY	8.23%
2021 Q3	160.95 Million CNY	64.91%
2021 FY	174.19 Million CNY	107.73%
2021 Q1	87.85 Million CNY	4.76%
2021 Q2	97.59 Million CNY	11.1%
2020 Q1	23.89 Million CNY	450.07%
2020 Q3	75.2 Million CNY	194.99%
2020 Q2	25.49 Million CNY	6.7%
2020 FY	83.85 Million CNY	1830.46%
2020 Q4	83.85 Million CNY	11.5%
2019 Q3	- CNY	-100.0%
2019 FY	4.34 Million CNY	0.0%
2019 Q4	4.34 Million CNY	0.0%
2019 Q2	7.18 Million CNY	409.72%
2019 Q1	1.4 Million CNY	0.0%
2018 Q4	- CNY	0.0%
2018 Q1	- CNY	0.0%
2018 Q3	- CNY	0.0%
2018 FY	- CNY	0.0%
2017 FY	- CNY	0.0%
2017 Q4	- CNY	0.0%
2016 FY	- CNY	0.0%

Peer Total Debt Comparison of CStone Pharmaceuticals

Name	Total Debt	Total Debt Difference
Uni-Bio Science Group Limited	52.86 Million HKD	-587.476%
CK Life Sciences Int'l., (Holdings) Inc.	5.93 Billion HKD	93.872%